Literature DB >> 20154684

CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.

LiPing Liu1, Abdelmadjid Belkadi, Lindsey Darnall, Taofang Hu, Caitlin Drescher, Anne C Cotleur, Dolly Padovani-Claudio, Tao He, Karen Choi, Thomas E Lane, Robert H Miller, Richard M Ransohoff.   

Abstract

Multiple sclerosis is an inflammatory demyelinating disorder of the CNS. Recent studies have suggested diverse mechanisms as underlying demyelination, including a subset of lesions induced by an interaction between metabolic insult to oligodendrocytes and inflammatory mediators. For mice of susceptible strains, cuprizone feeding results in oligodendrocyte cell loss and demyelination of the corpus callosum. Remyelination ensues and has been extensively studied. Cuprizone-induced demyelination remains incompletely characterized. We found that mice lacking the type 2 CXC chemokine receptor (CXCR2) were relatively resistant to cuprizone-induced demyelination and that circulating CXCR2-positive neutrophils were important for cuprizone-induced demyelination. Our findings support a two-hit process of cuprizone-induced demyelination, supporting the idea that multiple sclerosis pathogenesis features extensive oligodendrocyte cell loss. These data suggest that cuprizone-induced demyelination is useful for modeling certain aspects of multiple sclerosis pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154684      PMCID: PMC2827651          DOI: 10.1038/nn.2491

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  48 in total

1.  IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.

Authors:  E H Tran; E N Prince; T Owens
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

2.  Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury.

Authors:  R C Schreiber; K Krivacic; B Kirby; S A Vaccariello; T Wei; R M Ransohoff; R E Zigmond
Journal:  Neuroreport       Date:  2001-03-05       Impact factor: 1.837

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination.

Authors:  J L Mason; P Ye; K Suzuki; A J D'Ercole; G K Matsushima
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

5.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

Review 6.  The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

Authors:  G K Matsushima; P Morell
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

7.  Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier.

Authors:  E J McMahon; D N Cook; K Suzuki; G K Matsushima
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  Interferon-gamma protects against cuprizone-induced demyelination.

Authors:  X Gao; T A Gillig; P Ye; A J D'Ercole; G K Matsushima; B Popko
Journal:  Mol Cell Neurosci       Date:  2000-10       Impact factor: 4.314

Review 9.  Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

Authors:  H Lassmann; W Brück; C Lucchinetti
Journal:  Trends Mol Med       Date:  2001-03       Impact factor: 11.951

10.  Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination.

Authors:  Helga Jurevics; Carrie Largent; Janell Hostettler; Deanne W Sammond; Glenn K Matsushima; Amber Kleindienst; Arrel D Toews; Pierre Morell
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

View more
  104 in total

1.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

2.  Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.

Authors:  LiPing Liu; Lindsey Darnall; Taofang Hu; Karen Choi; Thomas E Lane; Richard M Ransohoff
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

3.  IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination.

Authors:  Julian Zimmermann; Michael Emrich; Marius Krauthausen; Simon Saxe; Louisa Nitsch; Michael T Heneka; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

4.  Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone.

Authors:  Handi Zhang; Yanbo Zhang; Haiyun Xu; Lingyan Wang; Jinsong Zhao; Junhui Wang; Zhijun Zhang; Qingrong Tan; Jiming Kong; Qingjun Huang; Xin-Min Li
Journal:  Neurosci Bull       Date:  2013-08-29       Impact factor: 5.203

5.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors:  Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal:  JCI Insight       Date:  2019-04-02

6.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

7.  Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses.

Authors:  Adam Denes; Barry W McColl; Sophie F Leow-Dyke; Katie Z Chapman; Neil E Humphreys; Richard K Grencis; Stuart M Allan; Nancy J Rothwell
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

8.  Functional defect of peripheral neutrophils in mice with induced deletion of CXCR2.

Authors:  Liping Liu; MeiZhang Li; Lisa C Spangler; Charles Spear; Mike Veenstra; Lindsey Darnall; Cathleen Chang; Anne C Cotleur; Richard M Ransohoff
Journal:  Genesis       Date:  2013-06-24       Impact factor: 2.487

Review 9.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

Review 10.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.